Mohammad Mahdi Forghanifard

22PUBLICATIONS
7CO-AUTHORS
Predictive and prognostic markersMolecular targetsInstruments and techniquesChemotherapyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jun 13, 2026
EZH2 as regulator of stemness signature and driver of esophageal squamous cell carcinomas.

|May 28, 2026
EZH2 Upregulates Notch Signaling Pathway Genes and Increases Cell Migration in Gastric Cancers.

|Dec 19, 2025
GLI1-VENTX Expression Pattern as a Prognostic Value for Non-Metastatic Early Esophageal Squamous Cell Carcinoma.

Elaheh Gheybi, Fatemeh Molaei, Mohammad Mahdi Forghanifard

|Jun 24, 2025
Author Correction: EZH2 regulates oncomiR-200c and EMT markers in esophageal squamous cell carcinomas.

Fatemeh Nourmohammadi, Mohammad Mahdi Forghanifard, Mohammad Reza Abbaszadegan

|Jan 16, 2025
Sustanon suppresses spermatogenesis and increases cell death.

Fatemeh Kamali Hosseinzadeh, Jina Khayatzadeh, Mohammad Mahdi Forghanifard

|Jan 14, 2025
PYGO2 promotes resistance to chemotherapy via reducing apoptosis and G2/M cell cycle arrest in esophageal carcinoma cells.

Fatemeh Ardalan Moghadam Al, Mohammad Mahdi Forghanifard, Vajiheh Zarrinpour

Pageof 4

Frequent Collaborators

2 joint publications

Mona Khoshbakht

2 joint publications

Hossein Aghamollaei

2 joint publications

Jafar Amani

1 joint publications

Fatemeh Ardalan Moghadam Al